Vetera WNV is for the vaccination of healthy horses 4 months of age or older as an aid in the prevention of viremia and mortality, and an aid in the reduction of severity of clinical disease caused by West Nile Virus. The duration of immunity is at least 12 months.
Safe for use in horses as young as 4 months of age, including pregnant mares
Contains equine origin 2005 West Nile Virus isolate (E159™)
Incorporates the Carbimmune® adjuvant formulation to optimize performance and minimize reactions
Unique ULTRAFIL® purification technology minimizes non-relevant protein presented to the immune system
Available in single dose pre-filled syringes or color-coded 10 dose vials
Features
At least 12 month WNV DOI
Safe for use in horses as young as 4 months of age, including pregnant mares
Contains equine origin 2005 West Nile Virus isolate (E159™)
Incorporates the Carbimmune® adjuvant formulation
Unique ULTRAFIL® purification technology
Benefits
Safety and efficacy proven in 4 month old horses, including pregnant mares
Contemporary WNV strain offers most up-to-date protection
Adjuvant formulation specifically customized to optimize performance and minimize reactions
Purification process minimizes non-relative protein being presented to the immune system
Shake well before use. Using aseptic technique, inoculate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3-4 weeks using a different injection site. Revaccinate annually and prior to anticipated exposure with a single 1 mL intramuscular dose.
Validate your login